Mary E. Napier

6.8k total citations · 1 hit paper
48 papers, 5.5k citations indexed

About

Mary E. Napier is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Mary E. Napier has authored 48 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biomaterials, 18 papers in Biomedical Engineering and 13 papers in Molecular Biology. Recurrent topics in Mary E. Napier's work include Nanoparticle-Based Drug Delivery (20 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Mary E. Napier is often cited by papers focused on Nanoparticle-Based Drug Delivery (20 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Mary E. Napier collaborates with scholars based in United States, France and Sweden. Mary E. Napier's co-authors include Joseph M. DeSimone, J. Christopher Luft, Patrick D. Pohlhaus, Stephanie E. A. Gratton, Patricia A. Ropp, Victoria J. Madden, Jin Wang, James D. Byrne, Shaomin Tian and Jillian L. Perry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Investigation.

In The Last Decade

Mary E. Napier

44 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effect of particle design on cellular internalization pathways

2008 2.4k citations Stephanie E. A. Gratton, Patricia A. Ropp et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary E. Napier United States	27	2.6k	2.2k	2.1k	1.2k	507	48	5.5k
Nicholas A. Peppas United States	23	2.9k 1.1×	1.9k 0.8×	1.9k 0.9×	890 0.7×	977 1.9×	44	5.3k
Kyeongsoon Park South Korea	46	3.4k 1.3×	3.5k 1.6×	2.8k 1.4×	1.6k 1.3×	872 1.7×	168	8.4k
Juliana M. Chan United States	17	3.0k 1.1×	2.3k 1.0×	2.3k 1.1×	1.0k 0.9×	823 1.6×	21	5.9k
Anna Musyanovych Germany	39	3.1k 1.2×	2.2k 1.0×	1.8k 0.9×	1.8k 1.5×	495 1.0×	81	6.6k
J. Clifford Murray United Kingdom	20	2.7k 1.0×	1.9k 0.8×	3.1k 1.5×	984 0.8×	615 1.2×	45	6.7k
Omid Veiseh United States	38	4.5k 1.7×	4.3k 1.9×	2.9k 1.4×	1.4k 1.1×	578 1.1×	79	9.0k
Santosh Aryal United States	42	3.9k 1.5×	4.1k 1.8×	3.4k 1.6×	1.4k 1.2×	524 1.0×	108	8.2k
Juan L. Vivero‐Escoto United States	31	2.8k 1.1×	2.5k 1.1×	1.7k 0.8×	3.3k 2.7×	302 0.6×	67	6.8k
João Rodrigues Portugal	38	2.2k 0.9×	2.1k 0.9×	1.7k 0.8×	1.1k 0.9×	361 0.7×	124	6.0k
Jennifer B. Hall United States	15	2.2k 0.8×	1.5k 0.7×	1.6k 0.8×	1.4k 1.2×	362 0.7×	17	4.5k

Countries citing papers authored by Mary E. Napier

Since Specialization

Citations

This map shows the geographic impact of Mary E. Napier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Napier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Napier more than expected).

Fields of papers citing papers by Mary E. Napier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Napier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Napier. The network helps show where Mary E. Napier may publish in the future.

Co-authorship network of co-authors of Mary E. Napier

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Napier. A scholar is included among the top collaborators of Mary E. Napier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Napier. Mary E. Napier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gharpure, Kshipra M., Kevin S. Chu, Charles J. Bowerman, et al.. (2014). Metronomic Docetaxel in PRINT Nanoparticles and EZH2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer. Molecular Cancer Therapeutics. 13(7). 1750–1757. 26 indexed citations

Xu, Jing, J. Christopher Luft, Xianwen Yi, et al.. (2013). RNA Replicon Delivery via Lipid-Complexed PRINT Protein Particles. Molecular Pharmaceutics. 10(9). 3366–3374. 36 indexed citations

Jones, Stephen, Reid A. Roberts, Gregory R. Robbins, et al.. (2013). Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. Journal of Clinical Investigation. 123(7). 3061–3073. 166 indexed citations

Wang, Yapei, James D. Byrne, Mary E. Napier, & Joseph M. DeSimone. (2012). Engineering nanomedicines using stimuli-responsive biomaterials. Advanced Drug Delivery Reviews. 64(11). 1021–1030. 70 indexed citations

Dunn, Stuart S., Shaomin Tian, Steven Blake, et al.. (2012). Reductively Responsive siRNA-Conjugated Hydrogel Nanoparticles for Gene Silencing. Journal of the American Chemical Society. 134(17). 7423–7430. 134 indexed citations

Merkel, Timothy J., Ashish Pandya, Mary E. Napier, et al.. (2012). Low Modulus Biomimetic Microgel Particles with High Loading of Hemoglobin. Biomacromolecules. 13(9). 2748–2759. 79 indexed citations

Chu, Kevin S., Warefta Hasan, Sumit Rawal, et al.. (2012). Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine Nanotechnology Biology and Medicine. 9(5). 686–693. 127 indexed citations

Xu, Jing, Jin Wang, J. Christopher Luft, et al.. (2012). Rendering Protein-Based Particles Transiently Insoluble for Therapeutic Applications. Journal of the American Chemical Society. 134(21). 8774–8777. 58 indexed citations

Parrott, Matthew C., et al.. (2012). Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT Nanoparticles. Journal of the American Chemical Society. 134(18). 7978–7982. 107 indexed citations

10.

Wang, Jin, James D. Byrne, Mary E. Napier, & Joseph M. DeSimone. (2011). More Effective Nanomedicines through Particle Design. Small. 7(14). 1919–1931. 375 indexed citations

11.

Pillai, Jonathan, Stuart S. Dunn, Mary E. Napier, & Joseph M. DeSimone. (2011). Novel platforms for vascular carriers with controlled geometry. IUBMB Life. 63(8). 596–606. 19 indexed citations

12.

Hasan, Warefta, Kevin S. Chu, Anuradha Gullapalli, et al.. (2011). Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer. Nano Letters. 12(1). 287–292. 143 indexed citations

13.

Werner, Michael E., Jonathan A. Copp, Shrirang Karve, et al.. (2011). Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy. ACS Nano. 5(11). 8990–8998. 107 indexed citations

14.

Galloway, Ashley L., Andrew Murphy, Jason P. Rolland, et al.. (2010). Micromolding for the Fabrication of Biological Microarrays. Methods in molecular biology. 671. 249–260. 3 indexed citations

15.

Gratton, Stephanie E. A., Mary E. Napier, Patricia A. Ropp, Shaomin Tian, & Joseph M. DeSimone. (2008). Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles. Pharmaceutical Research. 25(12). 2845–2852. 79 indexed citations

16.

Gratton, Stephanie E. A., Stuart Williams, Mary E. Napier, et al.. (2008). The Pursuit of a Scalable Nanofabrication Platform for Use in Material and Life Science Applications. Accounts of Chemical Research. 41(12). 1685–1695. 110 indexed citations

17.

Napier, Mary E. & Joseph M. DeSimone. (2007). Nanoparticle Drug Delivery Platform. Polymer Reviews. 47(3). 321–327. 74 indexed citations

18.

Napier, Mary E., et al.. (2005). Electrocatalytic Oxidation of DNA-Wrapped Carbon Nanotubes. Journal of the American Chemical Society. 127(34). 11952–11953. 55 indexed citations

19.

Napier, Mary E. & H. Holden Thorp. (1999). Electrocatalytic Oxidation of Nucleic Acids at Electrodes Modified with Nylon and Nitrocellulose Membranes. Journal of Fluorescence. 9(3). 181–186. 11 indexed citations

20.

Napier, Mary E. & Peter C. Stair. (1991). Perfluoroalkylether reactions on iron and oxygen covered iron surfaces studied using x-ray photoelectron spectroscopy and secondary ion mass spectrometry. Journal of Vacuum Science & Technology A Vacuum Surfaces and Films. 9(3). 649–652. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact